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Background. Typhoid and paratyphoid remain the most common bloodstream infections in many resource-poor settings. The 
World Health Organization recommends typhoid conjugate vaccines for country-specific introduction, but questions regarding 
typhoid and paratyphoid epidemiology persist, especially regarding their severity in young children.
Methods. We conducted enteric fever surveillance in Bangladesh from 2004 through 2016 in the inpatient departments of 2 
pediatric hospitals and the outpatient departments of 1 pediatric hospital and 1 private consultation clinic. Blood cultures were con-
ducted at the discretion of the treating physicians; cases of culture-confirmed typhoid/paratyphoid were included. Hospitalizations 
and durations of hospitalizations were used as proxies for severity in children <12 years old.
Results. We identified 7072 typhoid and 1810 paratyphoid culture-confirmed cases. There was no increasing trend in the pro-
portion of paratyphoid over the 13 years. The median age in the typhoid cases was 60 months, and 15% of the cases occurred in 
children <24 months old. The median age of the paratyphoid cases was significantly higher, at 90 months (P < .001); 9.4% were in 
children <24 months old. The proportion of children (<12 years old) hospitalized with typhoid and paratyphoid (32% and 21%, 
respectively) decreased with age; there was no significant difference in durations of hospitalizations between age groups. However, 
children with typhoid were hospitalized for longer than those with paratyphoid.
Conclusions. Typhoid and paratyphoid fever are common in Dhaka, including among children under 2 years old, who have 
equivalent disease severity as older children. Early immunization with typhoid conjugate vaccines could avert substantial morbidity, 
but broader efforts are required to reduce the paratyphoid burden.
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Typhoid and paratyphoid, collectively known as enteric fever, 
are among the most common bacterial causes of morbidity 
worldwide, with the greatest burden in low- and middle-income 
countries [1]. Salmonella enterica subspecies enterica serovar 
Typhi (Salmonella Typhi), the causative agent of typhoid, is esti-
mated to cause about 12 million illnesses and 128 000 deaths, 
and Salmonella enterica subspecies enterica serovar Paratyphi 
(Salmonella Paratyphi) A, B, and C, the causative agents of para-
typhoid, are estimated to cause 4 million illnesses and 25 000 
deaths annually [2, 3]. Recently, the World Health Organization 
(WHO) recommended typhoid conjugate vaccines (TCVs) in 
settings with high burdens and prequalified the first TCV [4]. 
There is no vaccine for paratyphoid. Countries are now fac-
ing important decisions regarding vaccine target groups and 
introduction strategies that require contemporary and locally 
relevant epidemiological data. Current estimates are primarily 
derived from sporadic, historical studies, and suffer from coarse 
geographical and temporal resolutions.
For effective implementation of the TCV, important ques-
tions regarding typhoid and paratyphoid epidemiology remain 
to be answered. For decades, typhoid was not considered severe 
enough in children under 2 years old to warrant treatment or 
hospitalization [5]. A few recent studies identified typhoid in 
young children, but severity in this age group remains largely 
unknown [6–8]. With the widespread use of antibiotics, case 
fatality rates and severe consequences of enteric fever, like intes-
tinal perforation and peritonitis, have decreased significantly 
[9]. With low numbers of obvious, severe clinical outcomes, 
evaluating severity in endemic countries is difficult, yet neces-
sary for informed policy decisions.
Typhoid and paratyphoid are considered a single disease, 
with the management of paratyphoid based on lessons learned 
from typhoid studies; yet, data on severities of illnesses from 
paratyphoid versus typhoid are conflicting [10, 11]. This is of 
specific interest in light of recent reports of increasing trends of 
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data sets [12, 13]. Most epidemiological data are obtained from 
hospital inpatient departments (IPD), but in endemic coun-
tries, a large number of patients seek care and are treated at out-
patient departments (OPD) [14–16].
We initiated enteric fever surveillance in 2004 in Bangladesh, 
where no typhoid vaccines are used. The surveillance was con-
ducted in the IPDs of the 2 largest pediatric hospitals and the 
OPDs of the largest pediatric hospital and a private consultation 
clinic. We describe the (1) trend in typhoid and paratyphoid 
cases, (2) age distribution of cases, and (3) severity by age of labo-
ratory-confirmed cases of typhoid and paratyphoid, using hospi-
talizations and durations of hospital stays as proxies for severity.
METHODS
Study Sites, Population, and Case Definitions
This study included 3 sites in Dhaka, Bangladesh: (1) Dhaka 
Shishu Hospital (DSH), (2) Shishu Shasthya Foundation 
Hospital (SSFH), and (3) an outpatient-based diagnostic center, 
the Popular Diagnostic Center (PDC). With 640 beds, DSH is 
the largest pediatric hospital in Bangladesh, and provides pri-
mary to tertiary care to patients up to 18 years of age; 47% of 
patients are treated free of cost. SSFH is the second-largest pedi-
atric hospital, with 200 beds for children up to 14 years of age; 
about 5% of the beds are dedicated to those unable to pay. PDC 
is among the largest private consultation centers, and serves 
patients of all ages.
For IPD-based surveillance to capture hospitalized enteric 
fever cases, we included cases from the IPDs of both DSH and 
SSFH. For OPD-based surveillance, we included cases from 
the OPDs and emergency rooms of both DSH and PDC. Blood 
cultures were conducted at the discretion of the treating phy-
sicians. We enrolled patients with positive blood cultures for 
Salmonella Typhi or Paratyphi.
Etiology Detection
Blood cultures were performed using standard methods [17]. 
We aseptically obtained 2–3 milliliters of blood, which was 
inoculated into trypticase soy broth supplemented with sodium 
polyanethole sulphonate (0.25%) and isovitalex (1%). Incubated 
blood culture bottles were sub-cultured on the second, third, 
and fifth days of incubation. Identification of Salmonella Typhi/
Paratyphi isolates was confirmed using standard biochemical 
tests and agglutination with Salmonella species and serovar-spe-
cific antisera (Ramel, Thermo Fisher Scientific). Laboratory 
methods for blood culture and organism identification were 
consistent over the reporting period.
Data Collection and Analysis
For enrolled cases, we collected the patient’s age, the presence of 
hospitalization, the duration of hospital stay, and hospital out-
comes from hospital and clinic records. We analyzed the pro-
portion of typhoid and paratyphoid cases, the age distribution, 
and the number of patients hospitalized. Many caregivers in 
Bangladesh do not know the exact age of the child, and round 
up to the closest year. To assess the age distributions of cases 
under 5 years, age smoothing was conducted. For children over 
12 months old, the exact age was not always known, but we used 
the date of birth of the child if it was available. The remain-
ing cases with estimated ages were allocated evenly across the 
months of that year, or “smoothed.” We used hospitalizations 
and durations of hospitalizations as proxies of disease sever-
ity. The age distribution of the care-seeking populations varied 
between our study sites, as DSH and SSF are pediatric hospi-
tals and PDC provides care to all age groups. In the hospitals, 
>95% of cases are in patients <144 months old (12 years old); 
therefore, we limited the analyses on the severity of typhoid and 
paratyphoid to only cases of children <12 years old. We used 
the Chi-square test to assess whether the proportion of typhoid/
paratyphoid cases was progressively increasing or decreasing 
and the risks of hospitalization with age. We used the Wilcoxon 
rank-sum test (or Kruskal–Wallis test, depending on the group 
numbers) for assessing the differences in age distributions of 
typhoid/paratyphoid cases treated in the OPD and IPD and for 
differences in the durations of hospitalization between typhoid/
paratyphoid cases and in different age groups of typhoid/para-
typhoid. We used the z-test for evaluating differences in the 
proportion of hospitalized typhoid and paratyphoid cases in 
children under 12 years old.
Ethical Clearance
The protocols were approved by the ethics review committees of 
the Bangladesh Institute of Child Health, DSH. Blood samples 
were collected and received at the laboratory as part of routine 
clinical care, and informed consent was obtained from parents 
or caregivers for other aspects of the study, including data collec-
tion and the use of specimens for additional laboratory analyses.
RESULTS
Proportion of Typhoid and Paratyphoid Fever Cases
From 2004 through 2016, we identified 7072 cases that were 
blood culture–positive for Salmonella Typhi and 1810 cases 
that were positive for Salmonella Paratyphi A, with relevant 
clinical data for downstream analyses (Figure 1). In total, 60% 
(5296/8882) of the cases were enrolled in an outpatient-based 
diagnostic center, PDC, which serves patients of all age groups. 
During this period, Paratyphi A accounted for 20% of the 
typhoidal Salmonella isolates. While this fluctuated moderately 
from year to year (peak of 30% in 2011, trough of 15% in 2005), 
there was no increasing or decreasing trend over the 13-year 
study period (Figure 2).
Age Distribution and Estimated Vaccine Coverage
There were 3 children <1 month old who had blood cul-
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patient; 15% (1025/7072) of cases were in children <24 months 
old and 46% (3251/7072) in children <60 months old (Figure 
3A). Only 1.5% (107/7072) cases occurred in children <9 
months of age (Figure 3B). While the median age of typhoid 
cases among children was 60 months (interquartile range 
[IQR] 33–120) and a peak was seen between 36 and 60 months, 
a second, smaller peak was apparent at 216 to 264 months (18 
to 22 years; Figure 3A).
The youngest paratyphoid patients were <1 month old (n 
&#x003D; 3) and the oldest was 73 years old; 9.4% (171/1810) 
of cases were in children <24 months old and 31.5% (570/1810) 
were in children <60 months old (Figure 3D and 3E). The 
median age of all cases was 90 months (IQR 48–228 m), com-
pared with 60 months in typhoid cases (P < .001). Similar to 
typhoid, we also observed a bimodal age distribution among the 
paratyphoid cases. The peaks here were broader, where the first 
Figure 1. Typhoid and paratyphoid cases enrolled in this study. Abbreviations: IPD, inpatient departments; OPD, outpatient departments.
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peak occurred at 12 to 84 months and the second peak at 204 to 
336 months (17 to 28 years).
The overall age distributions of both typhoid and paraty-
phoid cases in children <12 years old remained fairly consistent 
through the 13 years of our surveillance (Figure 3C and 3F).
Severity of Typhoid and Paratyphoid by Age
Hospital outcomes were available for 1188 typhoid cases: 2 
(0.2%) case patients died, 36 (3%) left against medical advice, 
4 (0.3%) were referred to other hospitals, and 1146 (96.5%) 
were discharged. Of the 164 paratyphoid cases for which hos-
pital outcomes were available, 7 (4.2%) left against medical 
advice and the remaining 157 (95.8%) were discharged. No 
deaths among paratyphoid-infected patients were confirmed. 
As severe complications or deaths due to enteric fever were 
uncommon, it was not possible to perform robust statistical 
analyses to compare severities of the diseases in different age 
groups. Therefore, we used hospitalizations and durations of 
Figure 3. Age distribution of enteric fever cases in Bangladesh. A, Age distribution of all typhoid cases. B, Age distribution of typhoid cases in children under 5 years old. For 
children above 12 months old, the exact age, shown in black, was known only in some cases, where the exact date of birth of the child was available. The remaining cases, 
where the exact birth date was unavailable, and approximate age was recorded, were allocated evenly across months of that year, or “smoothed,” shown in gray. C, Proportion 
of typhoid cases in different age groups each year; only cases of children <12 years old were included here. D, Age distribution of all paratyphoid cases. E, Age distribution of 
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hospitalizations as proxies of severity in children <12 years old. 
This data set consisted of 5647 typhoid cases (median age 48 
months, IQR 28–78) and 1155 paratyphoid cases (median age 
60 months, IQR 33–84 months; P < .001).
Hospitalization as a Proxy for Severity
Among the 5647 typhoid patients under 12 years old, 1806 (32%) 
were hospitalized and the remaining 3841 (68%) were treated 
in an OPD. By age, 41.5% (425/1025) of children <2 years old 
were hospitalized, compared to 35% (789/2226) of children 2–5 
years old and 24.7% (592/2396) of those 5–12 years old. Younger 
children were more likely to be hospitalized; the proportion of 
children hospitalized with typhoid fever decreased with age (P 
< .001; Figure 4A). Overall, the median age of the hospitalized 
children was 42 months (IQR 24–69), compared to 54 months 
(IQR 30–84) for children treated in an OPD (P < .001).
For 1155 paratyphoid cases, the proportion of children hos-
pitalized decreased with increasing age (P < .001; Figure 4B); 
35.7% (61/171) of children <2 years old were hospitalized, com-
pared to 21.6% (86/399) of children 2–5 years old and 15.6% 
(91/585) of children 5–12 years old. The median age of hospi-
talized paratyphoid cases was 46 months (IQR 22–72) and of 
OPD cases was 60 months (IQR 36–87; P < .001). Compared 
to typhoid, there was a lower overall proportion of paratyphoid 
cases hospitalized (21% [238/1155] compared to 32%; P < .001).
Hospital Duration as a Proxy for Severity
Hospital duration data were available for 1217 of 1806 hospital-
ized typhoid cases, with a median of 6 days (IQR 5–9). There 
was no significant difference in the durations of hospitalization 
with age (Figure 4C). For paratyphoid cases, the durations of 
hospital stays were available for 161 of 238 hospitalized cases, 
and the median duration was also 6 days (IQR 4–7), with no 
significant difference in the durations of hospitalization with 
age (Figure 4D). Although the median durations of hospitaliza-
tion of typhoid and paratyphoid cases did not differ, a Wilcoxon 
rank-sum test showed significant difference in the distribution 
of durations of hospitalization (P < .001); typhoid cases were 
more likely to remain hospitalized longer than paratyphoid 
cases (Figure 4E).
Figure 4. Severity of enteric fever with age. A, Proportion of typhoid patients hospitalized in the IPD (black), compared to proportion of typhoid patients treated in the OPD 
(gray), in each age group. B, Proportion of paratyphoid patients hospitalized in the IPD (black), compared to proportion of paratyphoid patients treated in the OPD (gray), in 
each age group. C, Distribution of durations of hospital stays of typhoid cases in each age group. D, Distribution of durations of hospital stays of paratyphoid cases in each 
age group. E, Distribution of durations of hospital stays of both typhoid and paratyphoid cases. Abbreviations: IPD, inpatient departments; OPD, outpatient departments. 
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DISCUSSION
Most low- and middle-income countries have introduced, or 
are in the process of introducing, the pneumococcal conjugate 
vaccine and Haemophilus influenzae type b vaccine, based on 
relevant burden and vaccine efficacy data, which has signifi-
cantly decreased the burden of pneumococcal and Haemophilus 
influenzae type b diseases. However, it remains difficult to make 
evidence-based decisions on the control of enteric fever, as only 
a few, small, incomprehensive studies have addressed disease 
epidemiology. With the recent WHO prequalification of TCV, 
a detailed understanding of typhoid in infants and young chil-
dren is important for developing the most effective vaccination 
strategy. We conducted enteric fever surveillance from 2004 
through 2016 to generate data on typhoid and paratyphoid 
cases in Bangladesh, where Salmonella Typhi and Paratyphi A 
are the most common causes of bloodstream infections in chil-
dren over 2 months of age [17, 18].
In recent years, there have been several reports of increasing 
proportions of paratyphoid, as compared to typhoid [12, 13]. 
Our surveillance revealed no trend of change, corroborating 
results from a meta-analysis of data from India [19]. We did 
observe moderate year-to-year fluctuations in the proportions 
of the 2 diseases, which could be due to a number of factors, 
including changing patterns in the antimicrobial susceptibility 
of Salmonella Typhi and Paratyphi A or other environmental 
factors. For example, in Bangladesh, the multidrug resistance 
(resistance to ampicillin, cotrimoxazole, and chloramphenicol) 
of Salmonella Typhi has significantly decreased in recent years; 
there is no multidrug-resistant Paratyphi A strain [14]. Almost 
all Salmonella Typhi and Paratyphi A strains are non-suscepti-
ble to fluoroquinolones [17]. As antibiotic consumption prior to 
seeking care is very common, the presentation of cases at a facil-
ity depends on the available antibiotics in the market, dynamics 
of antimicrobial susceptibility patterns of the organisms, and 
rates of treatment failure in the community [15].
In concordance with the few studies that looked at the prev-
alence of typhoid in children <5 years old, here 15% of cases 
were in children <2 years old and 46% were in patients <5 years 
old. In a study conducted in 2001, through a year of surveillance 
with 391 typhoid cases, our group had demonstrated that 27% 
of typhoid fever cases were in children <2 years old and 54% 
were in patients <5 years old [7]. The proportions depicted in 
the current study are lower than our previous studies, probably 
because we included both pediatric hospitals and private con-
sultation centers that serve all age groups. The findings are simi-
lar to the disease burden data among a preschool children group 
in India (44% were <60 months old; n &#x003D; 63 cases) and 
in a slum population of Bangladesh (60% were <60 months old; 
n &#x003D; 49 cases) [6, 20].
The WHO has recommended TCV in children as young as 
6 months and adults up to 45 years living in typhoid endemic 
areas, with an emphasis on the routine, programmatic 
administration of TCV at the same time as other vaccine visits 
at 9 months of age or by 2 years of age [4]. Our data on the age 
distribution of typhoid cases illustrate that if TCV is adminis-
tered at (1) 6 months, 0.5% of the cases will be missed, (2) if at 9 
months, 1.5% will be missed, or (3) if at 24 months, 15% will be 
missed. These findings emphasize the need for starting vaccina-
tion as early as 6 or 9 months.
We also noticed a rise in the number of cases in adults aged 
18 to 22 years, which is probably due to this population leav-
ing home to start undergraduate studies or jobs and having 
increased exposure to outside food. This bimodal peak suggests 
that a catch-up vaccination program could reduce the popula-
tion burden and may decrease overall transmission.
In our study, children with paratyphoid were generally 
older than children with typhoid (median age 90 months vs 60 
months, respectively), but 9.4% and 31.5% of paratyphoid cases 
occurred in children under 2 and 5 years old, respectively, with 
a similar peak in young adults. A study conducted in a general 
hospital in Nepal that serves patients of all ages also depicted 
a higher median age of paratyphoid patients, compared to 
typhoid patients [21].
In Bangladesh and the surrounding region, most health-
care costs are paid out of pocket and, therefore, the most 
impoverished seek care only when absolutely necessary; most 
enteric fever cases are empirically treated at the OPDs of hos-
pitals or community clinics [22]. Patients are admitted in an 
IPD only when they are very sick and/or are not responding 
to treatment. Hospitalized patients are eager to leave when 
they feel slightly better and/or are no longer able to afford the 
costs [22]. Furthermore, amidst fierce competition for beds, 
hospital physicians advise OPD-based treatment if the case is 
not considered severe enough to require hospitalization [23]. 
Based on these accounts and the rarity of known complica-
tions of enteric fever, we selected hospitalizations and dura-
tions of hospital stays as proxies of severity.
The proportion of children hospitalized with typhoid 
decreased with age, and younger children were significantly 
more likely to be hospitalized. While it is possible that younger 
children are more likely to be hospitalized than older children 
with the same degree of severity of the disease, the data delin-
eate that typhoid is definitely not less severe or benign in young 
children. There was no difference in the durations of hospital 
stays between age groups, further illustrating equal severities of 
disease cases across age groups. Paratyphoid cases are less likely 
to be hospitalized than typhoid cases (21% vs 32%, respec-
tively), and those paratyphoid patients who are hospitalized 
are likely to stay for a shorter duration. Although paratyphoid 
appears less severe than typhoid and there was no increase over 
the surveillance period, it is still an important disease that fre-
quently affects young children, leads to the hospitalization of 
one-fourth of the affected children, and, hence, merits immedi-
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An important limitation of the study is that it was not 
designed to actively identify suspected enteric fever cases. The 
use of blood cultures was dependent on the treating physicians: 
it likely differed between facilities and may have biased age pat-
terns and the proportion of typhoid and paratyphoid cases. Our 
study included hospitalized typhoid/paratyphoid cases only 
from pediatric hospitals and severity analyses were conducted 
only in children <12 years old. Further work is required to 
understand and compare the severities of the diseases in older 
age groups.
Important strengths of our study include (1) the large num-
ber of culture-proved cases, which allowed for robust analyses 
of age distributions, (2) analyses of both proportions of hospi-
talizations and durations of hospital stays for the assessment of 
severity, and (3) a long surveillance period, with data collection 
for many years, which confirmed consistency instead of pro-
viding snapshots of the disease. This knowledge is crucial, both 
to control the diseases with appropriate utilization of interven-
tions and as baseline data for future vaccine impact studies. 
Monitoring the age distribution of typhoid cases and the bur-
den of paratyphoid will be important following the introduc-
tion of TCVs.
CONCLUSIONS
With 8882 cases of enteric fever identified from 2004 through 
2016, our findings demonstrate that typhoid and paratyphoid 
are common in young children. Although the case fatality rate 
is low, the emergence of widespread antimicrobial resistance 
is threatening effective treatment and, if the right intervention 
strategies are not instituted soon, increases in mortality rates in 
the near future may occur. We found that 15% of cases occur 
in children under 2 years old, with equivalent disease sever-
ity as seen in older children. Early immunization with TCVs 
could avert substantial morbidity. Efforts to reduce exposure 
to contaminated water and food, as well as developing vaccines 
against paratyphoid, are important steps for the prevention and 
control of enteric fever.
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